Key points

Key points

  • Chemotherapy dose standardisation, where hospital trusts move to a system of dose banding, has the potential to offer considerable benefits for patients, providers and commissioners.

  • In 2016, NHS England's Medicines Optimisation and Chemotherapy Clinical Reference Groups coordinated a national approach to chemotherapy dose standardisation. Shortly following this, NHS England published a set of product specifications to support the production and supply of ready-made chemotherapy medicines.

  • Cancer features in the NHS Long Term Plan published in January 2019.

  • Options for local implementation:

    • All NHS England commissioned providers of chemotherapy should move to prescribing and supplying a range of intravenous anticancer therapy in accordance with a nationally approved set of dose bands and product specifications.